65 related articles for article (PubMed ID: 2041578)
1. Dipyrone enhances intracellular accumulation and cytotoxicity of adriamycin in human chronic myeloid leukemia cells.
Chitnis MP; Kamath NS; Parekh HK; Advani SH
Neoplasma; 1991; 38(2):185-91. PubMed ID: 2041578
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone & adriamycin cytotoxicity enhanced by reserpine in human chronic myeloid leukaemia cells.
Chitnis MP; Kamath NS; Advani SH
Indian J Med Res; 1989 Jun; 90():197-202. PubMed ID: 2767744
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of human chronic myeloid leukemia cells insensitivity to adriamycin and mitoxanthrone cytotoxicity by quinidine.
Parekh HK; Advani SH; Chitnis MP
Neoplasma; 1990; 37(6):717-25. PubMed ID: 2274089
[TBL] [Abstract][Full Text] [Related]
4. Response of human chronic myeloid leukemia cells to mitoxantrone cytotoxicity: potentiation by bepridil, a calcium channel antagonist.
Parekh HK; Shallom JM; Advani SH; Chitnis MP
Neoplasma; 1991; 38(6):575-81. PubMed ID: 1766484
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin conjugates of human transferrin bind transferrin receptors and kill K562 and HL60 cells.
Berczi A; Barabas K; Sizensky JA; Faulk WP
Arch Biochem Biophys; 1993 Jan; 300(1):356-63. PubMed ID: 8424669
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of chronic myeloid leukemia cells to adriamycin cytotoxicity by clofibrate.
Parekh H; Satyamoorthy K; Advani S; Chitnis M
Tumori; 1990 Feb; 76(1):18-21. PubMed ID: 2321268
[TBL] [Abstract][Full Text] [Related]
7. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.
Chitnis MP; Kamath NS
Oncology; 1987; 44(1):47-50. PubMed ID: 3561929
[TBL] [Abstract][Full Text] [Related]
8. FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line.
Natazuka T
Kobe J Med Sci; 1992 Dec; 38(6):347-63. PubMed ID: 1284834
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
Maca RD
Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
[TBL] [Abstract][Full Text] [Related]
11. Bepridil enhances adriamycin-induced DNA biosynthesis inhibition in human myeloid leukemia cells.
Parekh H; Advani S; Chitnis M
Sel Cancer Ther; 1990; 6(4):183-91. PubMed ID: 2094938
[TBL] [Abstract][Full Text] [Related]
12. Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
Vichi PJ; Tritton TR
Cancer Res; 1993 Nov; 53(21):5237-43. PubMed ID: 8106144
[TBL] [Abstract][Full Text] [Related]
13. In vitro modulation of adriamycin and mitoxantrone cytotoxicity by hyperthermia and diazepam, in human chronic myeloid leukemia cells.
Juvekar AS; Chitnis MP; Advani SH
Neoplasma; 1987; 34(2):199-204. PubMed ID: 3474531
[TBL] [Abstract][Full Text] [Related]
14. Single and combination treatment with vitamin K3 and adriamycin: in vitro effects on cell survival and DNA damage in human chronic myeloid leukemia cells.
Parekh H; Chavan S; Advani S; Chitnis M
Sel Cancer Ther; 1991; 7(3):127-35. PubMed ID: 1771299
[TBL] [Abstract][Full Text] [Related]
15. Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells.
Satyamoorthy K; Chitnis MP; Pradhan SG; Advani SH
Oncology; 1989; 46(2):128-31. PubMed ID: 2710477
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
17. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
18. Effect of mitoxantrone on human chronic myeloid leukemia cells in vitro, combined with hyperthermia.
Juvekar AS; Chitnis MP; Adwankar MK; Advani SH
Neoplasma; 1986; 33(4):477-82. PubMed ID: 3463880
[TBL] [Abstract][Full Text] [Related]
19. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
[TBL] [Abstract][Full Text] [Related]
20. Differential alteration of cellular lipids in drug sensitive and resistant P388 leukemia cells by clofibrate: effects on mitoxantrone cytotoxicity.
Parekh H; Chitnis M
Tumori; 1991 Apr; 77(2):105-11. PubMed ID: 2048221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
